TreeWAS – Variant ID: rs77530448

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
I69.4 Sequelae of stroke, not specified as haemorrhage or infarction	0.062	0.938	0.000
I69 Sequelae of cerebrovascular disease	0.059	0.941	0.000
I63 Cerebral infarction	0.055	0.945	0.000
I60-I69 Cerebrovascular diseases	0.055	0.945	0.000
I63.9 Cerebral infarction, unspecified	0.051	0.949	0.000
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.000	0.950	0.050
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.000	0.952	0.048
I63.2 Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries	0.047	0.953	0.000
I69.1 Sequelae of intracerebral haemorrhage	0.046	0.954	0.000
I64 Stroke, not specified as haemorrhage or infarction	0.046	0.954	0.000
I69.2 Sequelae of other nontraumatic intracranial haemorrhage	0.046	0.954	0.000
I69.0 Sequelae of subarachnoid haemorrhage	0.045	0.955	0.000
I63.8 Other cerebral infarction	0.044	0.956	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.000	0.956	0.044
I63.5 Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries	0.043	0.957	0.000
I62 Other nontraumatic intracranial haemorrhage	0.043	0.957	0.000
I63.3 Cerebral infarction due to thrombosis of cerebral arteries	0.043	0.957	0.000
I69.3 Sequelae of cerebral infarction	0.043	0.957	0.000
I61 Intracerebral haemorrhage	0.042	0.958	0.000
I63.4 Cerebral infarction due to embolism of cerebral arteries	0.041	0.959	0.000
I63.6 Cerebral infarction due to cerebral venous thrombosis, nonpyogenic	0.040	0.960	0.000
I63.1 Cerebral infarction due to embolism of precerebral arteries	0.040	0.960	0.000
I63.0 Cerebral infarction due to thrombosis of precerebral arteries	0.040	0.960	0.000
C85.1 B-cell lymphoma, unspecified	0.000	0.960	0.040
I60 Subarachnoid haemorrhage	0.040	0.960	0.000
I68 Cerebrovascular disorders in diseases classified elsewhere	0.039	0.961	0.000
I66 Occlusion and stenosis of cerebral arteries, not resulting in cerebral infarction	0.039	0.961	0.000
I69.8 Sequelae of other and unspecified cerebrovascular diseases	0.038	0.961	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.000	0.962	0.038
C90 Multiple myeloma and malignant plasma cell neoplasms	0.000	0.962	0.038
C83 Diffuse non-Hodgkin's lymphoma	0.000	0.962	0.038
C81 Hodgkin's disease	0.000	0.962	0.038
I62.0 Subdural haemorrhage (acute) (nontraumatic)	0.037	0.963	0.000
I61.8 Other intracerebral haemorrhage	0.037	0.963	0.000
I67 Other cerebrovascular diseases	0.037	0.963	0.000
C88 Malignant immunoproliferative diseases	0.000	0.964	0.036
C83.3 Large cell (diffuse)	0.000	0.965	0.035
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.000	0.965	0.035
C85.0 Lymphosarcoma	0.000	0.965	0.035
C92 Myeloid leukaemia	0.000	0.966	0.034
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.000	0.966	0.034
C81.9 Hodgkin's disease, unspecified	0.000	0.966	0.034
C90.0 Multiple myeloma	0.000	0.967	0.033
I61.1 Intracerebral haemorrhage in hemisphere, cortical	0.033	0.967	0.000
I60.7 Subarachnoid haemorrhage from intracranial artery, unspecified	0.032	0.968	0.000
I61.0 Intracerebral haemorrhage in hemisphere, subcortical	0.032	0.968	0.000
C95 Leukaemia of unspecified cell type	0.000	0.968	0.032
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.968	0.031
C94 Other leukaemias of specified cell type	0.000	0.968	0.031
C93 Monocytic leukaemia	0.000	0.968	0.031
C86 Other specified types of T/NK-cell lymphoma	0.000	0.968	0.031
I60.2 Subarachnoid haemorrhage from anterior communicating artery	0.031	0.969	0.000
C90.2 Plasmacytoma, extramedullary	0.000	0.969	0.031
I62.1 Nontraumatic extradural haemorrhage	0.031	0.969	0.000
I67.8 Other specified cerebrovascular diseases	0.031	0.969	0.000
I61.3 Intracerebral haemorrhage in brain stem	0.031	0.969	0.000
I61.6 Intracerebral haemorrhage, multiple localised	0.030	0.970	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.000	0.970	0.030
I67.2 Cerebral atherosclerosis	0.030	0.970	0.000
I60.6 Subarachnoid haemorrhage from other intracranial arteries	0.030	0.970	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.000	0.970	0.030
I60.3 Subarachnoid haemorrhage from posterior communicating artery	0.029	0.971	0.000
I65 Occlusion and stenosis of precerebral arteries, not resulting in cerebral infarction	0.029	0.971	0.000
I60.5 Subarachnoid haemorrhage from vertebral artery	0.029	0.971	0.000
I60.4 Subarachnoid haemorrhage from basilar artery	0.029	0.971	0.000
I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation	0.029	0.971	0.000
C92.0 Acute myeloid leukaemia	0.000	0.971	0.029
I61.5 Intracerebral haemorrhage, intraventricular	0.028	0.971	0.000
I66.9 Occlusion and stenosis of unspecified cerebral artery	0.028	0.972	0.000
I66.8 Occlusion and stenosis of other cerebral artery	0.028	0.972	0.000
I66.4 Occlusion and stenosis of multiple and bilateral cerebral arteries	0.028	0.972	0.000
I66.3 Occlusion and stenosis of cerebellar arteries	0.028	0.972	0.000
I66.2 Occlusion and stenosis of posterior cerebral artery	0.028	0.972	0.000
I66.1 Occlusion and stenosis of anterior cerebral artery	0.028	0.972	0.000
I66.0 Occlusion and stenosis of middle cerebral artery	0.028	0.972	0.000
I68.8 Other cerebrovascular disorders in diseases classified elsewhere	0.028	0.972	0.000
I68.2 Cerebral arteritis in other diseases classified elsewhere	0.028	0.972	0.000
I68.1 Cerebral arteritis in infectious and parasitic diseases classified elsewhere	0.028	0.972	0.000
I68.0 Cerebral amyloid angiopathy	0.028	0.972	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.000	0.972	0.028
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.000	0.972	0.028
I61.2 Intracerebral haemorrhage in hemisphere, unspecified	0.028	0.972	0.000
C90.3 Solitary plasmacytoma	0.000	0.972	0.028
C90.1 Plasma cell leukaemia	0.000	0.972	0.028
C83.7 Burkitt's tumour	0.000	0.973	0.027
C83.6 Undifferentiated (diffuse)	0.000	0.973	0.027
C83.5 Lymphoblastic (diffuse)	0.000	0.973	0.027
C83.4 Immunoblastic (diffuse)	0.000	0.973	0.027
C83.2 Mixed small and large cell (diffuse)	0.000	0.973	0.027
I60.1 Subarachnoid haemorrhage from middle cerebral artery	0.027	0.973	0.000
C81.7 Other Hodgkin's disease	0.000	0.973	0.027
C81.4 Lymphocyte-rich classical Hodgkin lymphoma	0.000	0.973	0.027
C81.3 Lymphocytic depletion	0.000	0.973	0.027
C81.2 Mixed cellularity	0.000	0.973	0.027
C81.1 Nodular sclerosis	0.000	0.973	0.027
C81.0 Lymphocytic predominance	0.000	0.973	0.027
I67.1 Cerebral aneurysm, nonruptured	0.027	0.973	0.000
I67.7 Cerebral arteritis, not elsewhere classified	0.026	0.973	0.000
I67.6 Nonpyogenic thrombosis of intracranial venous system	0.026	0.973	0.000
I67.5 Moyamoya disease	0.026	0.973	0.000
I67.4 Hypertensive encephalopathy	0.026	0.973	0.000
I67.3 Progressive vascular leukoencephalopathy	0.026	0.973	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.000	0.973	0.026
I62.9 Intracranial haemorrhage (nontraumatic), unspecified	0.026	0.973	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.000	0.974	0.026
I61.4 Intracerebral haemorrhage in cerebellum	0.026	0.974	0.000
C83.1 Small cleaved cell (diffuse)	0.000	0.974	0.026
C88.9 Malignant immunoproliferative disease, unspecified	0.000	0.974	0.026
C88.7 Other malignant immunoproliferative diseases	0.000	0.974	0.026
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.000	0.974	0.026
C88.3 Immunoproliferative small intestinal disease	0.000	0.974	0.026
C88.2 Gamma heavy chain disease	0.000	0.974	0.026
C88.1 Alpha heavy chain disease	0.000	0.974	0.026
C83.0 Small cell (diffuse)	0.000	0.974	0.026
Z74.0 Reduced mobility	0.025	0.975	0.000
C92.9 Myeloid leukaemia, unspecified	0.000	0.975	0.025
C92.8 Acute myeloid leukaemia with multilineage dysplasia	0.000	0.975	0.025
C92.7 Other myeloid leukaemia	0.000	0.975	0.025
C92.6 Acute myeloid leukaemia with 11q23-abnormality	0.000	0.975	0.025
C92.5 Acute myelomonocytic leukaemia	0.000	0.975	0.025
C92.4 Acute promyelocytic leukaemia	0.000	0.975	0.025
C92.3 Myeloid sarcoma	0.000	0.975	0.025
C92.2 Subacute myeloid leukaemia	0.000	0.975	0.025
C82.0 Small cleaved cell, follicular	0.000	0.975	0.025
C82.6 Cutaneous follicle centre lymphoma	0.000	0.975	0.025
C82.5 Diffuse follicle centre lymphoma	0.000	0.975	0.025
C82.4 Follicular lymphoma grade IIIb	0.000	0.975	0.025
C82.3 Follicular lymphoma grade IIIa	0.000	0.975	0.025
I67.0 Dissection of cerebral arteries, nonruptured	0.024	0.975	0.000
I60.8 Other subarachnoid haemorrhage	0.024	0.976	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.000	0.976	0.024
I60.9 Subarachnoid haemorrhage, unspecified	0.024	0.976	0.000
C92.1 Chronic myeloid leukaemia	0.000	0.976	0.023
C95.9 Leukaemia, unspecified	0.000	0.976	0.023
C95.7 Other leukaemia of unspecified cell type	0.000	0.977	0.023
C95.2 Subacute leukaemia of unspecified cell type	0.000	0.977	0.023
C95.1 Chronic leukaemia of unspecified cell type	0.000	0.977	0.023
C95.0 Acute leukaemia of unspecified cell type	0.000	0.977	0.023
C91 Lymphoid leukaemia	0.000	0.977	0.023
C82.2 Large cell, follicular	0.000	0.977	0.023
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.000	0.977	0.023
C86.5 Angioimmunoblastic T-cell lymphoma	0.000	0.977	0.023
C86.4 Blastic NK-cell lymphoma	0.000	0.977	0.023
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.000	0.977	0.023
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.000	0.977	0.023
C86.1 Hepatosplenic T-cell lymphoma	0.000	0.977	0.023
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.000	0.977	0.023
C93.9 Monocytic leukaemia, unspecified	0.000	0.977	0.023
C93.7 Other monocytic leukaemia	0.000	0.977	0.023
C93.3 Juvenile myelomonocytic leukaemia	0.000	0.977	0.023
C93.2 Subacute monocytic leukaemia	0.000	0.977	0.023
C93.1 Chronic monocytic leukaemia	0.000	0.977	0.023
C93.0 Acute monocytic leukaemia	0.000	0.977	0.023
C94.7 Other specified leukaemias	0.000	0.977	0.023
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.000	0.977	0.023
C94.5 Acute myelofibrosis	0.000	0.977	0.023
C94.4 Acute panmyelosis	0.000	0.977	0.023
C94.3 Mast cell leukaemia	0.000	0.977	0.023
C94.2 Acute megakaryoblastic leukaemia	0.000	0.977	0.023
C94.1 Chronic erythraemia	0.000	0.977	0.023
C94.0 Acute erythraemia and erythroleukaemia	0.000	0.977	0.023
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.000	0.977	0.023
C96.8 Histiocytic sarcoma	0.000	0.977	0.023
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.000	0.977	0.023
C96.6 Unifocal Langerhans-cell histiocytosis	0.000	0.977	0.023
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.000	0.977	0.023
C96.4 Sarcoma of dendritic cells (accessory cells)	0.000	0.977	0.023
C96.3 True histiocytic lymphoma	0.000	0.977	0.023
C96.2 Malignant mast cell tumour	0.000	0.977	0.023
C96.1 Malignant histiocytosis	0.000	0.977	0.023
C96.0 Letterer-Siwe disease	0.000	0.977	0.023
C84.9 Mature T/NK-cell lymphoma, unspecified	0.000	0.978	0.021
C84.8 Cutaneous T-cell lymphoma, unspecified	0.000	0.978	0.021
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.000	0.978	0.021
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.000	0.978	0.021
C84.4 Peripheral T-cell lymphoma	0.000	0.978	0.021
C84.3 Lymphoepithelioid lymphoma	0.000	0.978	0.021
C84.2 T-zone lymphoma	0.000	0.978	0.021
C84.1 Sezary's diease	0.000	0.978	0.021
C84.0 Mycosis fungoides	0.000	0.978	0.021
I65.9 Occlusion and stenosis of unspecified precerebral artery	0.021	0.979	0.000
I65.8 Occlusion and stenosis of other precerebral artery	0.021	0.979	0.000
I65.3 Occlusion and stenosis of multiple and bilateral precerebral arteries	0.021	0.979	0.000
I65.1 Occlusion and stenosis of basilar artery	0.021	0.979	0.000
I65.0 Occlusion and stenosis of vertebral artery	0.021	0.979	0.000
I61.9 Intracerebral haemorrhage, unspecified	0.020	0.980	0.000
C84.5 Other and unspecified T-cell lymphomas	0.000	0.980	0.020
Z74 Problems related to care-provider dependency	0.019	0.981	0.000
C91.9 Lymphoid leukaemia, unspecified	0.000	0.983	0.017
C91.8 Mature B-cell leukaemia Burkitt-type	0.000	0.983	0.017
C91.7 Other lymphoid leukaemia	0.000	0.983	0.017
C91.6 Prolymphocytic leukaemia of T-cell type	0.000	0.983	0.017
C91.5 Adult T-cell leukaemia	0.000	0.983	0.017
C91.3 Prolymphocytic leukaemia	0.000	0.983	0.017
C91.2 Subacute lymphocytic leukaemia	0.000	0.983	0.017
C91.0 Acute lymphoblastic leukaemia	0.000	0.984	0.016
Z74.2 Need for assistance at home and no other household member able to render care	0.015	0.985	0.000
Z74.1 Need for assistance with personal care	0.015	0.985	0.000
C91.1 Chronic lymphocytic leukaemia	0.000	0.985	0.015
Z75.1 Person awaiting admission to adequate facility elsewhere	0.014	0.986	0.000
Z74.9 Problem related to care-provider dependency, unspecified	0.014	0.986	0.000
Z74.3 Need for continuous supervision	0.014	0.986	0.000
Z75 Problems related to medical facilities and other health care	0.014	0.986	0.000
Z70-Z76 Persons encountering health services in other circumstances	0.014	0.986	0.000
C91.4 Hairy-cell leukaemia	0.000	0.986	0.013
Z74.8 Other problems related to care-provider dependency	0.013	0.987	0.000
Z73 Problems related to life-management difficulty	0.012	0.988	0.000
K62.6 Ulcer of anus and rectum	0.012	0.988	0.000
Z76 Persons encountering health services in other circumstances	0.012	0.988	0.000
I65.2 Occlusion and stenosis of carotid artery	0.011	0.989	0.000
Z75.2 Other waiting period for investigation and treatment	0.011	0.989	0.000
Z73.9 Problem related to life-management difficulty, unspecified	0.011	0.989	0.000
Z75.8 Other problems related to medical facilities and other health care	0.011	0.989	0.000
Z75.5 Holiday relief care	0.010	0.990	0.000
Z75.9 Unspecified problem related to medical facilities and other health care	0.010	0.990	0.000
Z75.4 Unavailability and inaccessibility of other helping agencies	0.010	0.990	0.000
Z75.0 Medical services not available in home	0.010	0.990	0.000
Z70 Counselling related to sexual attitude, behaviour and orientation	0.010	0.990	0.000
Z76.9 Persons encountering health services in unspecified circumstances	0.010	0.990	0.000
Z73.8 Other problems related to life-management difficulty	0.009	0.990	0.000
Z75.3 Unavailability and inaccessibility of health-care facilities	0.009	0.991	0.000
Z76.3 Healthy person accompanying sick person	0.009	0.991	0.000
Z73.6 Limitation of activities due to disability	0.009	0.991	0.000
Z73.5 Social role conflict, not elsewhere classified	0.009	0.991	0.000
Z73.4 Inadequate social skills, not elsewhere classified	0.009	0.991	0.000
Z73.2 Lack of relaxation and leisure	0.009	0.991	0.000
Z73.1 Accentuation of personality traits	0.009	0.991	0.000
Z73.0 Burn-out	0.009	0.991	0.000
K91.4 Colostomy and enterostomy malfunction	0.009	0.991	0.000
I67.9 Cerebrovascular disease, unspecified	0.009	0.991	0.000
K91.3 Postoperative intestinal obstruction	0.009	0.991	0.000
Z09.2 Follow-up examination after chemotherapy for other conditions	0.000	0.991	0.009
Z76.5 Malingerer [conscious situation]	0.008	0.991	0.000
Z76.4 Other boarder in health-care facility	0.008	0.991	0.000
Z76.2 Health supervision and care of other healthy infant and child	0.008	0.991	0.000
Z76.1 Health supervision and care of foundling	0.008	0.991	0.000
Z76.0 Issue of repeat prescription	0.008	0.991	0.000
Z76.8 Persons encountering health services in other specified circumstances	0.008	0.992	0.000
Z73.3 Stress, not elsewhere classified	0.008	0.992	0.000
K91 Postprocedural disorders of digestive system, not elsewhere classified	0.008	0.992	0.000
Z70.9 Sex counselling, unspecified	0.007	0.993	0.000
Z70.8 Other sex counselling	0.007	0.993	0.000
Z70.3 Counselling related to combined concerns regarding sexual attitude, behaviour and orientation	0.007	0.993	0.000
Z70.2 Counselling related to sexual behaviour and orientation of third party	0.007	0.993	0.000
Z70.1 Counselling related to patient's sexual behaviour and orientation	0.007	0.993	0.000
Z70.0 Counselling related to sexual attitude	0.007	0.993	0.000
I34.0 Mitral (valve) insufficiency	0.007	0.993	0.000
N89.8 Other specified noninflammatory disorders of vagina	0.000	0.993	0.007
R47.8 Other and unspecified speech disturbances	0.007	0.993	0.000
Z71 Persons encountering health services for other counselling and medical advice, not elsewhere classified	0.007	0.993	0.000
L81.4 Other melanin hyperpigmentation	0.007	0.993	0.000
K91.1 Postgastric surgery syndromes	0.007	0.993	0.000
R47.1 Dysarthria and anarthria	0.007	0.993	0.000
R47 Speech disturbances, not elsewhere classified	0.006	0.994	0.000
Y60.0 During surgical operation	0.006	0.994	0.000
K91.9 Postprocedural disorder of digestive system, unspecified	0.006	0.994	0.000
K91.5 Postcholecystectomy syndrome	0.006	0.994	0.000
K91.2 Postsurgical malabsorption, not elsewhere classified	0.006	0.994	0.000
K91.0 Vomiting following gastro-intestinal surgery	0.006	0.994	0.000
I34.9 Nonrheumatic mitral valve disorder, unspecified	0.005	0.994	0.000
Z71.4 Alcohol abuse counselling and surveillance	0.005	0.995	0.000
Z71.3 Dietary counselling and surveillance	0.005	0.995	0.000
Z71.1 Person with feared complaint in whom no diagnosis is made	0.005	0.995	0.000
Z71.7 Human immunodeficiency virus [HIV] counselling	0.005	0.995	0.000
Z71.5 Drug abuse counselling and surveillance	0.005	0.995	0.000
Z71.0 Person consulting on behalf of another person	0.005	0.995	0.000
W19.9 Unspecified place	0.005	0.995	0.000
Z71.6 Tobacco abuse counselling	0.005	0.995	0.000
R47.0 Dysphasia and aphasia	0.005	0.995	0.000
Z71.8 Other specified counselling	0.005	0.995	0.000
I34 Nonrheumatic mitral valve disorders	0.005	0.995	0.000
T92.9 Sequelae of unspecified injury of upper limb	0.005	0.995	0.000
K51.8 Other ulcerative colitis	0.000	0.995	0.005
Z71.2 Person consulting for explanation of investigation findings	0.004	0.995	0.000
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified	0.004	0.996	0.000
T92.2 Sequelae of fracture at wrist and hand level	0.004	0.996	0.000
T92 Sequelae of injuries of upper limb	0.004	0.996	0.000
K51.0 Ulcerative (chronic) enterocolitis	0.000	0.996	0.004
K51 Ulcerative colitis	0.000	0.996	0.004
T81.3 Disruption of operation wound, not elsewhere classified	0.004	0.996	0.000
K51.9 Ulcerative colitis, unspecified	0.000	0.996	0.004
H53.0 Amblyopia ex anopsia	0.000	0.996	0.004
K22.2 Oesophageal obstruction	0.000	0.996	0.004
L81 Other disorders of pigmentation	0.004	0.996	0.000
T92.8 Sequelae of other specified injuries of upper limb	0.004	0.996	0.000
K51.4 Pseudopolyposis of colon	0.000	0.996	0.004
T92.1 Sequelae of fracture of arm	0.004	0.996	0.000
Z36.8 Other antenatal screening	0.000	0.996	0.004
I34.8 Other nonrheumatic mitral valve disorders	0.004	0.996	0.000
I34.2 Nonrheumatic mitral (valve) stenosis	0.004	0.996	0.000
L81.2 Freckles	0.004	0.996	0.000
T92.6 Sequelae of crushing injury and traumatic amputation of upper limb	0.004	0.996	0.000
K51.5 Mucosal proctocolitis	0.000	0.997	0.003
Z36.0 Antenatal screening for chromosomal anomalies	0.000	0.997	0.003
K31.8 Other specified diseases of stomach and duodenum	0.000	0.997	0.003
Z36 Antenatal screening	0.000	0.997	0.003
T92.5 Sequelae of injury of muscle and tendon of upper limb	0.003	0.997	0.000
T92.4 Sequelae of injury of nerve of upper limb	0.003	0.997	0.000
K51.3 Ulcerative (chronic) rectosigmoiditis	0.000	0.997	0.003
Z36.9 Antenatal screening, unspecified	0.000	0.997	0.003
K51.1 Ulcerative (chronic) ileocolitis	0.000	0.997	0.003
Z71.9 Counselling, unspecified	0.003	0.997	0.000
L81.8 Other specified disorders of pigmentation	0.003	0.997	0.000
L81.7 Pigmented purpuric dermatosis	0.003	0.997	0.000
L81.6 Other disorders of diminished melanin formation	0.003	0.997	0.000
L81.5 Leukoderma, not elsewhere classified	0.003	0.997	0.000
L81.3 Cafe au lait spots	0.003	0.997	0.000
L81.1 Chloasma	0.003	0.997	0.000
L81.0 Postinflammatory hyperpigmentation	0.003	0.997	0.000
Y60 Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care	0.003	0.997	0.000
T92.3 Sequelae of dislocation, sprain and strain of upper limb	0.003	0.997	0.000
Z36.2 Other antenatal screening based on amniocentesis	0.000	0.997	0.003
T92.0 Sequelae of open wound of upper limb	0.003	0.997	0.000
L03.2 Cellulitis of face	0.003	0.997	0.000
Z36.4 Antenatal screening for foetal growth retardation using ultrasound and other physical methods	0.000	0.997	0.003
K51.2 Ulcerative (chronic) proctitis	0.000	0.997	0.003
H53.8 Other visual disturbances	0.000	0.997	0.003
H53 Visual disturbances	0.000	0.997	0.003
Z36.5 Antenatal screening for isoimmunisation	0.000	0.997	0.003
Z36.1 Antenatal screening for raised alphafetoprotein level	0.000	0.997	0.003
R03.0 Elevated blood-pressure reading, without diagnosis of hypertension	0.000	0.997	0.003
S63.4 Traumatic rupture of ligament of finger at metacarpophalangeal and interphalangeal joint(s)	0.003	0.997	0.000
F20.0 Paranoid schizophrenia	0.003	0.997	0.000
H53.1 Subjective visual disturbances	0.000	0.997	0.003
S68.1 Traumatic amputation of other single finger (complete)(partial)	0.003	0.997	0.000
I31.9 Disease of pericardium, unspecified	0.000	0.997	0.003
L81.9 Disorder of pigmentation, unspecified	0.002	0.997	0.000
T47.0 Histamine H(2)-receptor antagonists	0.002	0.997	0.000
N39.8 Other specified disorders of urinary system	0.000	0.997	0.003
I34.1 Mitral (valve) prolapse	0.002	0.997	0.000
Y60.9 During unspecified surgical and medical care	0.002	0.997	0.000
Y60.8 During other surgical and medical care	0.002	0.997	0.000
Y60.7 During administration of enema	0.002	0.997	0.000
Y60.6 During aspiration, puncture and other catheterisation	0.002	0.997	0.000
Y60.5 During heart catheterisation	0.002	0.997	0.000
Y60.3 During injection or immunisation	0.002	0.997	0.000
Y60.2 During kidney dialysis or other perfusion	0.002	0.997	0.000
Y60.1 During infusion or transfusion	0.002	0.997	0.000
F20 Schizophrenia	0.002	0.998	0.000
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.002	0.998	0.000
N28.1 Cyst of kidney, acquired	0.000	0.998	0.002
T42.4 Benzodiazepines	0.002	0.998	0.000
K55.9 Vascular disorder of intestine, unspecified	0.002	0.998	0.000
M65.96 Synovitis and tenosynovitis, unspecified (Lower leg)	0.002	0.998	0.000
F25.9 Schizoaffective disorder, unspecified	0.002	0.998	0.000
F20.9 Schizophrenia, unspecified	0.002	0.998	0.000
F20.5 Residual schizophrenia	0.002	0.998	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.002	0.998	0.000
H53.6 Night blindness	0.000	0.998	0.002
H53.5 Colour vision deficiencies	0.000	0.998	0.002
H53.3 Other disorders of binocular vision	0.000	0.998	0.002
Y60.4 During endoscopic examination	0.002	0.998	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.002	0.998	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.002	0.998	0.000
M25.54 Pain in joint (Hand)	0.000	0.998	0.002
Z94.8 Other transplanted organ and tissue status	0.000	0.998	0.002
M46.99 Inflammatory spondylopathy, unspecified (Site unspecified)	0.002	0.998	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.002	0.998	0.000
H53.4 Visual field defects	0.000	0.998	0.002
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.002	0.998	0.000
K55.2 Angiodysplasia of colon	0.002	0.998	0.000
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.002	0.998	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.002	0.998	0.000
T90-T98 Sequelae of injuries, of poisoning and of other consequences of external causes	0.002	0.998	0.000
Z36.3 Antenatal screening for malformations using ultrasound and other physical methods	0.000	0.998	0.002
T91.3 Sequelae of injury of spinal cord	0.002	0.998	0.000
T40.4 Other synthetic narcotics	0.002	0.998	0.000
T45.5 Anticoagulants	0.002	0.998	0.000
F20.8 Other schizophrenia	0.002	0.998	0.000
F20.6 Simple schizophrenia	0.002	0.998	0.000
F20.4 Postschizophrenic depression	0.002	0.998	0.000
F20.3 Undifferentiated schizophrenia	0.002	0.998	0.000
F20.2 Catatonic schizophrenia	0.002	0.998	0.000
F20.1 Hebephrenic schizophrenia	0.002	0.998	0.000
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.002	0.998	0.000
T47.8 Other agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
T47.7 Emetics	0.002	0.998	0.000
T47.6 Antidiarrhoeal drugs	0.002	0.998	0.000
T47.5 Digestants	0.002	0.998	0.000
T47.4 Other laxatives	0.002	0.998	0.000
T47.3 Saline and osmotic laxatives	0.002	0.998	0.000
T47.2 Stimulant laxatives	0.002	0.998	0.000
T95 Sequelae of burns, corrosions and frostbite	0.002	0.998	0.000
D17.6 Benign lipomatous neoplasm of spermatic cord	0.002	0.998	0.000
K74.3 Primary biliary cirrhosis	0.000	0.998	0.002
S63.3 Traumatic rupture of ligament of wrist and carpus	0.002	0.998	0.000
Y43.3 Other antineoplastic drugs	0.000	0.998	0.002
Z72 Problems related to lifestyle	0.002	0.998	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.002	0.998	0.000
T45.1 Antineoplastic and immunosuppressive drugs	0.002	0.998	0.000
T95.3 Sequelae of burn, corrosion and frostbite of lower limb	0.002	0.998	0.000
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.002	0.998	0.000
T42.5 Mixed antiepileptics, not elsewhere classified	0.002	0.998	0.000
T42.3 Barbiturates	0.002	0.998	0.000
T42.2 Succinimides and oxazolidinediones	0.002	0.998	0.000
T42.0 Hydantoin derivatives	0.002	0.998	0.000
M06.90 Rheumatoid arthritis, unspecified (Multiple sites)	0.002	0.998	0.000
T36 Poisoning by systemic antibiotics	0.002	0.998	0.000
T45.0 Antiallergic and antiemetic drugs	0.002	0.998	0.000
K55 Vascular disorders of intestine	0.002	0.998	0.000
K60.1 Chronic anal fissure	0.002	0.998	0.000
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.002	0.998	0.000
T46.8 Antivaricose drugs, including sclerosing agents	0.002	0.998	0.000
T46.7 Peripheral vasodilators	0.002	0.998	0.000
T46.5 Other antihypertensive drugs, not elsewhere classified	0.002	0.998	0.000
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.002	0.998	0.000
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.002	0.998	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.002	0.998	0.000
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
T41 Poisoning by anaesthetics and therapeutic gases	0.002	0.998	0.000
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.002	0.998	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
Q85.9 Phakomatosis, unspecified	0.002	0.998	0.000
T91 Sequelae of injuries of neck and trunk	0.002	0.998	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.002	0.998	0.000
T45.8 Other primarily systemic and haematological agents	0.002	0.998	0.000
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
T45.6 Fibrinolysis-affecting drugs	0.002	0.998	0.000
T45.4 Iron and its compounds	0.002	0.998	0.000
T45.3 Enzymes, not elsewhere classified	0.002	0.998	0.000
T45.2 Vitamins, not elsewhere classified	0.002	0.998	0.000
T93.2 Sequelae of other fractures of lower limb	0.002	0.998	0.000
T93 Sequelae of injuries of lower limb	0.002	0.998	0.000
M65.34 Trigger finger-Hand	0.002	0.998	0.000
E21.3 Hyperparathyroidism, unspecified	0.002	0.998	0.000
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.002	0.998	0.000
F25 Schizoaffective disorders	0.002	0.998	0.000
T39.0 Salicylates	0.002	0.998	0.000
T94 Sequelae of injuries involving multiple and unspecified body regions	0.002	0.998	0.000
T97 Sequelae of toxic effects of substances chiefly nonmedicinal as to source	0.002	0.998	0.000
T96 Sequelae of poisoning by drugs, medicaments and biological substances	0.002	0.998	0.000
G61.0 Guillain-Barre syndrome	0.000	0.998	0.002
H53.9 Visual disturbance, unspecified	0.000	0.998	0.002
J35.0 Chronic tonsillitis	0.002	0.998	0.000
T46.4 Angiotensin-converting-enzyme inhibitors	0.002	0.998	0.000
N60.2 Fibroadenosis of breast	0.000	0.998	0.002
S63 Dislocation, sprain and strain of joints and ligaments at wrist and hand level	0.002	0.998	0.000
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
A41.8 Other specified septicaemia	0.000	0.998	0.002
H16.2 Keratoconjunctivitis	0.002	0.998	0.000
K13.0 Diseases of lips	0.000	0.998	0.002
L03.3 Cellulitis of trunk	0.002	0.998	0.000
T43.5 Other and unspecified antipsychotics and neuroleptics	0.002	0.998	0.000
R47-R49 Symptoms and signs involving speech and voice	0.002	0.998	0.000
T46.1 Calcium-channel blockers	0.002	0.998	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
T42.1 Iminostilbenes	0.002	0.998	0.000
T95.9 Sequelae of unspecified burn, corrosion and frostbite	0.002	0.998	0.000
T95.8 Sequelae of other specified burn, corrosion and frostbite	0.002	0.998	0.000
T95.4 Sequelae of burn and corrosion classifiable only according to extent of body surface involved	0.002	0.998	0.000
T95.2 Sequelae of burn, corrosion and frostbite of upper limb	0.002	0.998	0.000
T95.1 Sequelae of burn, corrosion and frostbite of trunk	0.002	0.998	0.000
T95.0 Sequelae of burn, corrosion and frostbite of head and neck	0.002	0.998	0.000
D22.6 Melanocytic naevi of upper limb, including shoulder	0.002	0.998	0.000
K55.0 Acute vascular disorders of intestine	0.002	0.998	0.000
R01.1 Cardiac murmur, unspecified	0.002	0.998	0.000
Q85 Phakomatoses, not elsewhere classified	0.002	0.998	0.000
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.002	0.998	0.000
D36.1 Peripheral nerves and autonomic nervous system	0.000	0.998	0.002
H54.7 Unspecified visual loss	0.000	0.998	0.002
K75.8 Other specified inflammatory liver diseases	0.000	0.998	0.002
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.002	0.998	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.002	0.998	0.000
T40.8 Lysergide [LSD]	0.002	0.998	0.000
T40.7 Cannabis (derivatives)	0.002	0.998	0.000
T40.5 Cocaine	0.002	0.998	0.000
T40.3 Methadone	0.002	0.998	0.000
T40.1 Heroin	0.002	0.998	0.000
T40.0 Opium	0.002	0.998	0.000
Z72.9 Problem related to lifestyle, unspecified	0.002	0.998	0.000
Z72.8 Other problems related to lifestyle	0.002	0.998	0.000
Z72.6 Gambling and betting	0.002	0.998	0.000
Z72.5 High-risk sexual behaviour	0.002	0.998	0.000
Z72.4 Inappropriate diet and eating habits	0.002	0.998	0.000
Z72.3 Lack of physical exercise	0.002	0.998	0.000
H16.9 Keratitis, unspecified	0.002	0.998	0.000
K55.8 Other vascular disorders of intestine	0.002	0.998	0.000
T36.0 Penicillins	0.001	0.998	0.000
T44.3 Other parasympatholytics [anticholinergics and antimuscarines] and spasmolytics, not elsewhere classified	0.002	0.998	0.000
G56.2 Lesion of ulnar nerve	0.002	0.998	0.000
K74.0 Hepatic fibrosis	0.000	0.998	0.002
Z04.8 Examination and observation for other specified reasons	0.000	0.998	0.002
L84 Corns and callosities	0.002	0.998	0.000
T98 Sequelae of other and unspecified effects of external causes	0.002	0.998	0.000
H18.8 Other specified disorders of cornea	0.002	0.998	0.000
Q85.8 Other phakomatoses, not elsewhere classified	0.002	0.998	0.000
T36.9 Systemic antibiotic, unspecified	0.001	0.998	0.000
T36.8 Other systemic antibiotics	0.001	0.998	0.000
T36.7 Antifungal antibiotics, systemically used	0.001	0.998	0.000
T36.6 Rifamycins	0.001	0.998	0.000
T36.5 Aminoglycosides	0.001	0.998	0.000
T36.4 Tetracyclines	0.001	0.998	0.000
T36.3 Macrolides	0.001	0.998	0.000
T36.2 Chloramphenicol group	0.001	0.998	0.000
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.001	0.998	0.000
H16 Keratitis	0.002	0.998	0.000
K55.1 Chronic vascular disorders of intestine	0.001	0.998	0.000
S63.5 Sprain and strain of wrist	0.002	0.998	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations